Investor Overview

Corporate Profile

Accuray develops, manufactures and sells radiation oncology systems that make cancer treatments shorter, safer, smarter and more effective. Accuray provides treatment delivery technologies that set the industry standard for precision and cover the full range of radiation therapy and radiosurgery treatments, as well as fully integrated software solutions that drive faster, smarter treatment planning.

Press Releases

April 24, 2018 at 7:30 AM EDT

Summary Toggle South Florida Radiation Oncology Treats First Cancer Patients Using Its New CyberKnife® M6™ System

Innovative Radiation Therapy Device Enables Cancer Center to Provide Faster, Extremely Precise Radiation Treatments SUNNYVALE, Calif. , April 24, 2018 /PRNewswire/ -- Accuray Incorporated's (NASDAQ: ARAY) CyberKnife ® M6™ System with the InCise™ Multileaf Collimator (MLC) is enabling clinicians at
April 17, 2018 at 7:30 AM EDT

Summary Toggle Accuray to Bring Patient-First Cancer Treatment Innovations to ESTRO 37

Unique Hologram Technology Will Showcase the Benefits Accuray Radiotherapy Systems and Software Solutions Provide to Patients SUNNYVALE, Calif. , April 17, 2018 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today it will be showcasing the benefits of its radiotherapy systems and

View All

Events

View All

Annual Reports

Filing date	Form
Aug 25, 2017	10-K
Aug 24, 2016	10-K

View All

Investor Relations

Innovating patient-first cancer treatments.

Investor Overview

Corporate Profile

Q3 2018 Accuray Incorporated Earnings Conference Call

Investor Relations

Innovating patient-first cancer treatments.

Investor Overview

Corporate Profile

Q3 2018 Accuray Incorporated Earnings Conference Call

Connect with us on social media.